Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06083467 · ClinicalTrials.gov registry record · NA

CW2IP2: Imaging and Diagnostic Assessments

A NA study of Tauopathies, sponsored by University of Pennsylvania.

Recruiting
Registry status
NA
Development phase
94
Enrollment target
1
Study location

NCT06083467: Recruiting NA study of Tauopathies, sponsored by University of Pennsylvania.

NCT06083467 is a NA study of Tauopathies that is actively recruiting participants, run by University of Pennsylvania. The registered enrollment target is 94 participants, above the 65-participant average among 5 other Tauopathies trials with a reported enrollment target (45% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06083467, a NA study of Tauopathies, is actively recruiting participants, sponsored by University of Pennsylvania.

RECRUITING
Registry status
NA
Development phase
94 participants
Enrollment target
1
Study location

Study Summary

This current protocol will provide the key data to help determine the specificity of our to-be-developed radiotracers by implementing a multi-site diagnostic assessment core and PET imaging of A-beta amyloid (may be completed at some sites as part of another protocol) that is commonly deposited in the brains of people with Parkinson's Disease (PD), Multiple System Atrophy (MSA), Progressive Supranuclear Palsy (PSP) or Frontotemporal Dementia (FTD) as well as healthy controls. This multicenter U19 grant is centered at U Pennsylvania (U Penn) (PI: Robert Mach) in collaboration with U Pittsburgh (Pitt), Yale University, U of California at San Francisco (UCSF) and Washington University in St. Louis (WU). U Penn will act as the single IRB of Record (sIRB) for this multi-center project and subjects will be recruited from all sites.

Conditions Studied

Tauopathies

Interventions

  • DIAGNOSTIC_TEST Brain MRI Scan
  • BEHAVIORAL Neurologic exam

Study Locations (1)

Pennsylvania

  • University of Pennsylvania - Philadelphia

Trial Details

FieldValue
Enrollment Target 94 participants
Start Date 2023-07-20
Est. Completion 2028-07-31
Phase NA

Sponsor

University of Pennsylvania

1,423 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06083467

The ClinicalTrials.gov registry entry for NCT06083467 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 94 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 65-participant average among 5 other Tauopathies trials with a reported enrollment target (45% higher). The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Tauopathies appearing as the primary indexed condition, and to 2 interventions - of which Brain MRI Scan is the first listed.

NCT06083467 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT06083467 about?

NCT06083467 is a clinical study titled "CW2IP2: Imaging and Diagnostic Assessments". This current protocol will provide the key data to help determine the specificity of our to-be-developed radiotracers by implementing a multi-site diagnostic assessment core and PET imaging of A-beta amyloid (may be completed at some sites as part of another protocol) that is commonly deposited in t...

What is the current status of trial NCT06083467?

This trial is currently recruiting. It is a NA study. The enrollment target is 94 participants. The study started on 2023-07-20. Estimated completion is 2028-07-31.

What conditions does trial NCT06083467 study?

This clinical trial studies the following conditions: Tauopathies.

What interventions are being tested in trial NCT06083467?

The interventions under investigation include: Brain MRI Scan (DIAGNOSTIC_TEST), Neurologic exam (BEHAVIORAL).

Who is sponsoring clinical trial NCT06083467?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06083467 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Tauopathies

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Tauopathies

All registered trials for this condition

Pennsylvania

All trials with a study site in Pennsylvania

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Related

Compare this shortlist side-by-side

Read our methodology - how this data is sourced, computed, and verified.
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.